TDRD1 and prostate carcinoma: Accordingly, overexpression of TDRD1 in ERG-negative LNCaP cells did not lead to changes in cell viability (data not shown), suggesting that expression of TDRD1 is not required for proliferation of ERG-rearranged prostate cancer cells in vitro.